Skip to main content
. 2019 Aug 17;8(8):1242. doi: 10.3390/jcm8081242

Figure 3.

Figure 3

Differences in serum LOXL2 concentration. A: n= 150, baseline at 891.80 ± 1616 pg/mL vs. 24 M at 328.07 ± 1415.03 pg/mL; p < 0.001. B: n = 212; non-significant fibrosis (kPa < 9) at 113.29 ± 176.96 pg/mL vs. significant fibrosis (kPa > 9) at 216.63 ± 347.92 pg/mL, p = 0.046, at 24 months. C: n = 215 diabetic patients, 231.30 ± 310.28 pg/mL vs. nondiabetics, 127.05 ± 224.15, p = 0.09.